Treatment of diabetes

A dual GLP-1/GIP receptor agonist administered in a fixed dose improves blood glucose control and reduces insulin resistance, addressing the limitations of current diabetes treatments by enhancing insulin sensitivity and promoting weight loss.

JP2026518009APending Publication Date: 2026-06-02CARMOT THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
CARMOT THERAPEUTICS INC
Filing Date
2024-04-23
Publication Date
2026-06-02

Smart Images

  • Figure 2026518009000085
    Figure 2026518009000085
  • Figure 2026518009000086
    Figure 2026518009000086
  • Figure 2026518009000087
    Figure 2026518009000087
Patent Text Reader

Abstract

This disclosure provides methods and compositions for treating patients with diabetes and / or obesity.
Need to check novelty before this filing date? Find Prior Art